Your browser doesn't support javascript.
loading
Long-read sequencing for fast and robust identification of correct genome-edited alleles: PCR-based and Cas9 capture methods.
McCabe, Christopher V; Price, Peter D; Codner, Gemma F; Allan, Alasdair J; Caulder, Adam; Christou, Skevoulla; Loeffler, Jorik; Mackenzie, Matthew; Malzer, Elke; Mianné, Joffrey; Nowicki, Krystian J; O'Neill, Edward J; Pike, Fran J; Hutchison, Marie; Petit-Demoulière, Benoit; Stewart, Michelle E; Gates, Hilary; Wells, Sara; Sanderson, Nicholas D; Teboul, Lydia.
Afiliação
  • McCabe CV; The Mary Lyon Centre, MRC Harwell, Oxfordshire, United Kingdom.
  • Price PD; The Mary Lyon Centre, MRC Harwell, Oxfordshire, United Kingdom.
  • Codner GF; The Mary Lyon Centre, MRC Harwell, Oxfordshire, United Kingdom.
  • Allan AJ; The Mary Lyon Centre, MRC Harwell, Oxfordshire, United Kingdom.
  • Caulder A; The Mary Lyon Centre, MRC Harwell, Oxfordshire, United Kingdom.
  • Christou S; The Mary Lyon Centre, MRC Harwell, Oxfordshire, United Kingdom.
  • Loeffler J; The Mary Lyon Centre, MRC Harwell, Oxfordshire, United Kingdom.
  • Mackenzie M; The Mary Lyon Centre, MRC Harwell, Oxfordshire, United Kingdom.
  • Malzer E; The Mary Lyon Centre, MRC Harwell, Oxfordshire, United Kingdom.
  • Mianné J; The Mary Lyon Centre, MRC Harwell, Oxfordshire, United Kingdom.
  • Nowicki KJ; The Mary Lyon Centre, MRC Harwell, Oxfordshire, United Kingdom.
  • O'Neill EJ; The Mary Lyon Centre, MRC Harwell, Oxfordshire, United Kingdom.
  • Pike FJ; The Mary Lyon Centre, MRC Harwell, Oxfordshire, United Kingdom.
  • Hutchison M; The Mary Lyon Centre, MRC Harwell, Oxfordshire, United Kingdom.
  • Petit-Demoulière B; Université de Strasbourg, CNRS, INSERM, Institut Clinique de la Souris (ICS), PHENOMIN, CELPHEDIA, Illkirch, France.
  • Stewart ME; The Mary Lyon Centre, MRC Harwell, Oxfordshire, United Kingdom.
  • Gates H; The Mary Lyon Centre, MRC Harwell, Oxfordshire, United Kingdom.
  • Wells S; Mammalian Genetics Unit, MRC Harwell, Oxfordshire, United Kingdom.
  • Sanderson ND; The Mary Lyon Centre, MRC Harwell, Oxfordshire, United Kingdom.
  • Teboul L; Nuffield Department of Clinical Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom.
PLoS Genet ; 20(3): e1011187, 2024 Mar.
Article em En | MEDLINE | ID: mdl-38457464
ABSTRACT

BACKGROUND:

Recent developments in CRISPR/Cas9 genome-editing tools have facilitated the introduction of precise alleles, including genetic intervals spanning several kilobases, directly into the embryo. However, the introduction of donor templates, via homology directed repair, can be erroneous or incomplete and these techniques often produce mosaic founder animals. Thus, newly generated alleles must be verified at the sequence level across the targeted locus. Screening for the presence of the desired mutant allele using traditional sequencing methods can be challenging due to the size of the interval to be sequenced, together with the mosaic nature of founders. METHODOLOGY/PRINCIPAL

FINDINGS:

In order to help disentangle the genetic complexity of these animals, we tested the application of Oxford Nanopore Technologies long-read sequencing at the targeted locus and found that the achievable depth of sequencing is sufficient to offset the sequencing error rate associated with the technology used to validate targeted regions of interest. We have assembled an analysis workflow that facilitates interrogating the entire length of a targeted segment in a single read, to confirm that the intended mutant sequence is present in both heterozygous animals and mosaic founders. We used this workflow to compare the output of PCR-based and Cas9 capture-based targeted sequencing for validation of edited alleles.

CONCLUSION:

Targeted long-read sequencing supports in-depth characterisation of all experimental models that aim to produce knock-in or conditional alleles, including those that contain a mix of genome-edited alleles. PCR- or Cas9 capture-based modalities bring different advantages to the analysis.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sistemas CRISPR-Cas / Edição de Genes Idioma: En Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sistemas CRISPR-Cas / Edição de Genes Idioma: En Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Reino Unido